Jean Ge will present a webinar for the Oligonucleotide Therapeutics Society (OTS) titled “Strategic IP for Oligonucleotide Therapeutics: Maximizing Innovation Value.” This talk will explore the essential elements of an effective IP strategy tailored for oligonucleotide therapeutics, balancing scientific innovation with commercial objectives. Jean will delve into the nuances of patent protection, examining how to develop a comprehensive patent portfolio for securing robust claims for novel oligonucleotides and specific therapeutic applications. She will also address the intricacies of navigating the prior art and ensuring freedom-to-operate within an increasingly crowded patent space.